FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

5527111000001106: Betahistine 16mg tablets 60 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22884501000001118 Betahistine 16mg tablets 60 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22884601000001119 Betahistine 16mg tablets 60 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

5 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Betahistine 16mg tablets 60 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Betahistine 16mg tablets 60 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Betahistine 16mg tablets 60 tablet Has VMP Betahistine 16mg tablets true Inferred relationship Existential restriction modifier
Betahistine 16mg tablets 60 tablet Has VMP Betahistine 16mg tablets false Inferred relationship Existential restriction modifier
Betahistine 16mg tablets 60 tablet Is pack of Product containing precisely betahistine 16 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Betahistine 16mg tablets 60 tablet Has active ingredient Betahistine dihydrochloride false Inferred relationship Existential restriction modifier
Betahistine 16mg tablets 60 tablet Has active ingredient Betahistine false Inferred relationship Existential restriction modifier
Betahistine 16mg tablets 60 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Betahistine 16mg tablets 60 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Betahistine 16mg tablets 60 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Betahistine 16mg tablets 60 tablet Has VMP Product containing precisely betahistine 16 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Betahistine 16mg tablets 60 tablet Has specific active ingredient Betahistine dihydrochloride true Inferred relationship Existential restriction modifier
Betahistine 16mg tablets 60 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Serc 16mg tablets (PI) (Dowelhurst Ltd) 60 tablet 3 x 20 tablets Is a True Betahistine 16mg tablets 60 tablet Inferred relationship Existential restriction modifier
Betahistine 16mg tablets (PI) (Dowelhurst Ltd) 60 tablet 3 x 20 tablets Is a True Betahistine 16mg tablets 60 tablet Inferred relationship Existential restriction modifier
Serc 16mg tablets (Doncaster Pharmaceuticals Ltd) 60 tablet Is a True Betahistine 16mg tablets 60 tablet Inferred relationship Existential restriction modifier
Serc 16mg tablets (Lexon (UK) Ltd) 60 tablet Is a True Betahistine 16mg tablets 60 tablet Inferred relationship Existential restriction modifier
Serc 16mg tablets (Mawdsley-Brooks & Company Ltd) 60 tablet Is a True Betahistine 16mg tablets 60 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start